Angiogenesis in psoriasis and psoriatic arthritis: clues to disease pathogenesis.

被引:48
作者
Leong T.T. [1 ]
Fearon U. [1 ]
Veale D.J. [1 ]
机构
[1] Department of Rheumatology, St. Vincent's University Hospital and The Conway Institute of Biomolecular and Biomedical Research, University College Dublin
关键词
Vascular Endothelial Growth Factor; Psoriasis; Infliximab; Pioglitazone; Psoriatic Arthritis;
D O I
10.1007/s11926-005-0044-5
中图分类号
学科分类号
摘要
Psoriasis is a common chronic dermatosis occurring in 2% of the population and associated with an inflammatory arthritis--psoriatic arthritis (PsA)--in up to 40% of cases. PsA accounts for approximately 15% of patients attending early synovitis clinics, therefore it represents the second most common diagnostic category after rheumatoid arthritis. There are a number of common pathogenic features that link the skin and the joint inflammatory processes. Angiogenesis appears to be a fundamental inflammatory response early in the pathogenesis and significant abnormalities of vascular morphology and angiogenic growth factors have been described in psoriasis and PsA. This paper will explore the recent published evidence to support the hypothesis that dysregulated angiogenesis provides a primary pathogenic mechanism in psoriasis skin and in the PsA joint.
引用
收藏
页码:325 / 329
页数:4
相关论文
共 50 条
  • [21] The Genetics of Psoriasis and Psoriatic Arthritis
    Chandran, Vinod
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2013, 44 (02) : 149 - 156
  • [22] EPIDEMIOLOGY OF PSORIASIS AND PSORIATIC ARTHRITIS
    Cimmino, M. A.
    REUMATISMO, 2007, 59 : 19 - 24
  • [23] Guidelines of care for the management of psoriasis and psoriatic arthritis
    Menter, Alan
    Korman, Neil J.
    Elmets, Craig A.
    Feldman, Steven R.
    Gelfand, Joel M.
    Gordon, Kenneth B.
    Gottlieb, Alice
    Koo, John Y. M.
    Lebwohl, Mark
    Leonardi, Craig L.
    Lim, Henry W.
    Van Voorhees, Abby S.
    Beutner, Karl R.
    Ryan, Caitriona
    Bhushan, Reva
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 65 (01) : 137 - 174
  • [24] Hyperuricemia in psoriasis and psoriatic arthritis
    Mohammed, Jinan Q.
    Mathkhor, Abdulsatar J.
    ANNALS OF CLINICAL AND ANALYTICAL MEDICINE, 2022, 13 (04): : 426 - 429
  • [25] Cardiovascular Disease and Risk Factors in Patients with Psoriasis and Psoriatic Arthritis
    Tobin, Anne-Marie
    Veale, Douglas J.
    Fitzgerald, Oliver
    Rogers, Sarah
    Collins, Paul
    O'Shea, Donal
    Kirby, Brian
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (07) : 1386 - 1394
  • [26] Metabolic Profiling in Rheumatoid Arthritis, Psoriatic Arthritis, and Psoriasis: Elucidating Pathogenesis, Improving Diagnosis, and Monitoring Disease Activity
    Dorochow, Erika
    Koehm, Michaela
    Hahnefeld, Lisa
    Gurke, Robert
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (06):
  • [27] Managing Patients with Psoriatic Disease: The Diagnosis and Pharmacologic Treatment of Psoriatic Arthritis in Patients with Psoriasis
    Philip J. Mease
    April W. Armstrong
    Drugs, 2014, 74 : 423 - 441
  • [28] Etiology and Pathogenesis of Psoriatic Arthritis
    Barnas, Jennifer L.
    Ritchlin, Christopher T.
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2015, 41 (04) : 643 - +
  • [29] Update in the pathogenesis of psoriatic arthritis
    Gonzalez, Segundo
    Queiro, Ruben
    Ballina, Javier
    REUMATOLOGIA CLINICA, 2012, 8 : S1 - S6
  • [30] The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis
    Andrew Blauvelt
    Andrea Chiricozzi
    Clinical Reviews in Allergy & Immunology, 2018, 55 : 379 - 390